A disintegrin and metalloprotease 17 (ADAM17) is involved in cancer development and progression due to its ability to shed many substrates involved in inflammation, growth factor receptor activation, angiogenesis, inter-cellular adhesion, drug-resistance and immune regulation, reviewed in [12,13,14,15,16,17]. This evidence concerns the gene ADAM17 and cancer.